MoneyWorks4Me

The sales for the June 2026 quarter moved up 37.08% to Rs. 7562.60 millions as compared to Rs. 5516.90 millions during the corresponding quarter last year.Profit after tax for the quarter ended June 2026 reported a huge growth of 89.87% to Rs. 644.80  millions from Rs. 339.60 millions.OP of the company witnessed a marginal growth to 1117.30 millions from 695.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 7562.60 5516.90 37.08 7562.60 5516.90 37.08 23190.60 20792.10 11.54
Other Income 81.80 73.70 10.99 81.80 73.70 10.99 212.80 224.00 -5.00
PBIDT 1117.30 695.20 60.72 1117.30 695.20 60.72 2903.70 2245.70 29.30
Interest 36.40 42.30 -13.95 36.40 42.30 -13.95 145.50 147.60 -1.42
PBDT 1080.90 652.90 65.55 1080.90 652.90 65.55 2646.10 2098.10 26.12
Depreciation 213.20 197.50 7.95 213.20 197.50 7.95 801.70 719.20 11.47
PBT 867.70 455.40 90.54 867.70 455.40 90.54 1844.40 1378.90 33.76
TAX 222.90 115.80 92.49 222.90 115.80 92.49 467.20 368.90 26.65
Deferred Tax 5.60 10.90 -48.62 5.60 10.90 -48.62 61.70 121.50 -49.22
PAT 644.80 339.60 89.87 644.80 339.60 89.87 1377.20 1010.00 36.36
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 14.77 12.60 17.24 14.77 12.60 17.24 12.52 10.80 15.93
Peers
Company Name CMP
Sun Pharma. Inds. 1842.55
Dr. Reddys Labs. 1141.00
Cipla 1366.30
Lupin 2075.00
Zydus Lifesciences 1113.45
View more..